ArticleOncoimmunology

Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models.

Grammatiki Fotaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.